Table: begin end state 1 5 non-cytoplasmic 6 29 transmembrane 30 35 cytoplasmic 36 54 transmembrane 55 63 non-cytoplasmic 64 86 transmembrane 87 95 cytoplasmic 96 117 transmembrane 118 142 non-cytoplasmic 143 163 transmembrane 164 189 cytoplasmic 190 211 transmembrane 212 223 non-cytoplasmic 224 250 transmembrane 251 257 cytoplasmic 258 280 transmembrane 281 311 non-cytoplasmic 312 334 transmembrane 335 338 cytoplasmic 339 367 transmembrane 368 385 non-cytoplasmic 386 407 transmembrane 408 412 cytoplasmic 413 436 transmembrane 437 455 non-cytoplasmic 456 474 transmembrane 475 506 cytoplasmic 507 526 transmembrane 527 545 non-cytoplasmic 546 568 transmembrane 569 578 cytoplasmic 579 600 transmembrane 601 613 non-cytoplasmic
Input: >AZOBR_RS11650 FitnessBrowser__azobra:AZOBR_RS11650 MSFYLVQFLSGLATAATLFLVSSGLTIVFGVTRIVNFAHGSFYMLGAYLGWMLVERWGST PLGFWGAVAAASLAVGLLGALMEVGLLRRLYRSPELFQLLATFGVVLVVQDAASWIWGSE DLLGRRAPGLRGSVDILDQPFPLYDLVLIGLGPLVLGLLWLLFNRTRWGTLVRAATQDRD MASALGVDPARLFTGVLFLGSALAGLGGALQVPREAVNLHMDMAIVVEAFVVVVVGGMGS LTGAFVASLLIGQLQAFGILVFPQITLVLVFLFMAVVLVIRPYGLLGRAEDAPPTAASPG PPLIAAADVARWAPALLLALLATVPLVAGDYALIVLTEVVILALLAASLHLLIGLGGLVS FGHAAYFGLGAYGAALLVKHFAAPMPLALAAAPLLAGLGALVAGWFCVRRSGLYFAMLTL AFAQIVWSVTFQWYGFTGGDNGILGVWPPDWAAGKAAYYWLTLAMAGGALLLLRRAAFAP FGYTLRAGRDSALRAESVGIDVRRHQWLSFALAGSAAGLAGGLYAFSKGSVFPTLMAVPV SVDALVMVLMGGIQTLSGPVVGAALFHLLETEAMSRTDWWRLVLGTIILVLVLAFPKGVA GFVRDLWTRGRDA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server